Svetlana V Vorona (Svetlana Vorona)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Respiratory Syndrome Coronavirus

Molecular Dynamics

Top Venues

Molecules (Basel, Switzerland)

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Tatyana A Grigoreva, Svetlana V Vorona, Daria S Novikova, Vyacheslav G Tribulovich
Rational Design Problematics of Peptide Nucleic Acids as SARS-CoV-2 Inhibitors. ACS omega 9 (30) (2024)
Tatyana A Grigoreva, Svetlana V Vorona, Daria S Novikova, Vyacheslav G Tribulovich
Rational Design Problematics of Peptide Nucleic Acids as SARS-CoV-2 Inhibitors. ACS omega 9 (30) (2024)
Daria S Novikova, Aleksandra V Sagaidak, Svetlana V Vorona, Vyacheslav G Tribulovich
A Visual Compendium of Principal Modifications within the Nucleic Acid Sugar Phosphate Backbone. Molecules (Basel, Switzerland) 29 (13) (2024)
Daria S Novikova, Aleksandra V Sagaidak, Svetlana V Vorona, Vyacheslav G Tribulovich
A Visual Compendium of Principal Modifications within the Nucleic Acid Sugar Phosphate Backbone. Molecules (Basel, Switzerland) 29 (13) (2024)
Daria S Novikova, Ammar Al Mustafa, Tatyana A Grigoreva, Svetlana V Vorona, Stanislav Selivanov, Vyacheslav G Tribulovich
NMR-Verified Dearomatization of 5,7-Substituted Pyrazolo[1,5-a]pyrimidines. Molecules (Basel, Switzerland) 28 (18) (2023)
Tatyana A Grigoreva, Aleksandra V Sagaidak, Svetlana V Vorona, Daria S Novikova, Vyacheslav G Tribulovich
ATP Mimetic Attack on the Nucleotide-Binding Domain to Overcome ABC Transporter Mediated Chemoresistance. ACS medicinal chemistry letters 13 (12) (2022)
Tatyana A Grigoreva, Svetlana V Vorona, Daria S Novikova, Vyacheslav G Tribulovich
Analysis of P-Glycoprotein Transport Cycle Reveals a New Way to Identify Efflux Inhibitors. ACS omega 7 (47) (2022)
Tatyana A Grigoreva, Aleksandra V Sagaidak, Svetlana V Vorona, Daria S Novikova, Vyacheslav G Tribulovich
ATP Mimetic Attack on the Nucleotide-Binding Domain to Overcome ABC Transporter Mediated Chemoresistance. ACS medicinal chemistry letters 13 (12) (2022)